XENTION

xention-logo

Xention Limited, a biopharmaceutical company, specializes in the discovery and development of ion channel-modulating drugs. It offers drugs for the treatment of atrial fibrillation, overactive bladder, pain, and autoimmune diseases. Xention Limited was formerly known as Xention Discovery Ltd. and later changed its name to Xention Limited in October 2006. The company was founded in 2002 and is based in Cambridge, the United Kingdom.

#SimilarOrganizations #People #Financial #Website #More

XENTION

Industry:
Biotechnology Developer Platform Medical

Founded:
2002-01-01

Address:
Pampisford, Cambridgeshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.xention.com

Total Employee:
11+

Status:
Active

Contact:
+441223493900

Email Addresses:
[email protected]

Total Funding:
32.33 M USD

Technology used in webpage:
SPF Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS BIG-IP Namesco DNS Namesco


Similar Organizations

arpida-ag-logo

Arpida AG

Arpida AG is a biopharmaceutical company that focused on the discovery and development of novel products.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

Current Employees Featured

john-ford_image

John Ford
John Ford Co-Founder & CSO @ Xention
Co-Founder & CSO

Founder


john-ford_image

John Ford

Investors List

abn-amro_image

ABN AMRO Fund

ABN AMRO Fund investment in Series B - Xention

crdit-agricole-rgions-investissement_image

Carvest Crédit Agricole Régions Investissement

Carvest Crédit Agricole Régions Investissement investment in Series B - Xention

forbion-capital-partners_image

Forbion Capital Partners

Forbion Capital Partners investment in Series B - Xention

albany-ventures_image

Albany Ventures Fund III

Albany Ventures Fund III investment in Series B - Xention

albany-ventures_image

Albany Ventures Fund III

Albany Ventures Fund III investment in Venture Round - Xention

btg_image

BTG International

BTG International investment in Venture Round - Xention

spark-ventures_image

Spark Ventures

Spark Ventures investment in Venture Round - Xention

mvm-life-science-partners_image

MVM Life Science Partners

MVM Life Science Partners investment in Venture Round - Xention

Official Site Inspections

http://www.xention.com

  • Host name: ztoa.namesco.net
  • IP address: 85.233.160.147
  • Location: United Kingdom
  • Latitude: 51.4964
  • Longitude: -0.1224
  • Timezone: Europe/London

Loading ...

More informations about "Xention"

Xention - Crunchbase Company Profile & Funding

Xention Limited, a biopharmaceutical company, specializes in the discovery and development of ion channel-modulating drugs. It offers drugs for the treatment of atrial fibrillation, overactive …See details»

Xention Company Profile - Office Locations, Competitors ... - Craft

Xention $32.3 m in total funding,. See insights on Xention including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Xention - 2025 Company Profile - Tracxn

Mar 21, 2025 Xention - Develops ion channel-modulating drugs for the treatment of atrial fibrillation, overactive bladder and chronic cough.. Raised a total funding of $19.3M over 3 …See details»

Xention Company Profile | Management and Employees List

Xention Profile and History. Xention is a leader in the discovery and development of ion channel-modulating drugs. The Company is developing a pipeline of innovative products for the …See details»

Xention 2025 Company Profile: Valuation, Funding & Investors

Xention General Information Description. Developer of novel therapies intended to improve the treatment of atrial fibrillation. The company's therapies develop drug candidates that modulate …See details»

Xention - VentureRadar

Xention is a biopharmaceutical company based in Cambridge UK specialising in the discovery and development of ion channel-modulating drugs. ... Find out more about Xention, Life …See details»

Xention - Overview, News & Similar companies | ZoomInfo.com

Who is Xention. Xention is a leader in the discovery and development of ion channel-modulating drugs. The Company is developing a pipeline of innovative products f or the treatment of atrial …See details»

Xention - Founders and Board of Directors - Tracxn

Xention's founders include Alexander Thomas Pasteur, David Raymond Ebsworth and 4 others.See details»

Xention Ltd - Company Profile and News - Bloomberg Markets

Company profile page for Xention Ltd including stock price, company news, executives, board members, and contact informationSee details»

Xention Ltd.:Company Profile & Technical Research,Competitor …

Xention Ltd. is a company that provides Drug, Medicine and more. Xention Ltd. is headquartered in United Kingdom SUFFOLK COUNTY. Xention Ltd. was founded in 2002.See details»

Xention | Forbion

Xention is developing novel therapies for the treatment of atrial fibrillation using its proprietary platform of ion channel drug discovery and development.See details»

Find and update company information - GOV.UK

Confirmation statement. Next statement date 31 May 2025 due by 14 June 2025. Last statement dated 31 May 2024See details»

Xention – Funding, Valuation, Investors, News

Nov 25, 2010 Essential stats, news, real-time insights on Xention. Connect with decision makers, founders, investors. Explore valuation, funding rounds, reviews.See details»

Xention Management Team - CB Insights

Explore {Xention's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»

Xention and Grünenthal enter Drug Discovery Collaboration in Ion ...

Feb 17, 2011 XENTION LTD announced that it has entered into a Research Agreement with the Grünenthal Group. Under the terms of the Agreement, Xention and GrÏ‹nenthal will combine …See details»

XENTION RAISES £11 MILLION IN PRIVATE EQUITY PLACEMENT

Oct 18, 2010 About Xention. Xention Discovery Ltd is a drug discovery company that utilizes proprietary technologies to accelerate the development of novel ion channel drugs, …See details»

Xention Raises £8 Million in Private Equity Placement

Nov 24, 2010 Funding to progress development of novel heart arrhythmia drugs.See details»

Xentino | Home Page

Xentino SI306 PoE series are 5-port (4xPOE + 1xSFP), unmanaged full Gigabit Ethernet switches compli ... Learn More . News . Xentino showing products at GiTEX 2023. 2023-10-10 …See details»

Xention Introduces Metrion Biosciences - Technology Networks

May 13, 2015 Metrion Biosciences will provide dedicated ion channel screening and assay development expertise to support enhanced cardiac safety assessment and the progression of …See details»

Xentino Technologies Corp. Corporate Presentation

Xentino has started its Taiwan based activities with bigger excitement, new generation dynamism and large range of products. 2002.01 –Xentino brand created 2003.06 –First ADSL USB …See details»

linkstock.net © 2022. All rights reserved